Cross-fund · 4 holders
PHAT
PHATHOM PHARMACEUTICALS INC
CUSIP 71722W107
4
Tracked holders
$152.7M
Aggregate value
12,180,274
Shares
4
Active funds
Funds holding PHAT
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $52.7M | — | -38,361 | -1.2% |
| BlackRock | Institutional | Q1 2026 | $45.1M | — | +506,448 | +14.2% |
| Millennium | Multi-Strategy | Q1 2026 | $44.7M | 0.02% | +1,940,729 | +93.2% |
| Citadel | Multi-Strategy | Q1 2026 | $10.2M | — | +507,943 | +123.8% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.